Cargando…
Evaluation of connectivity map shows limited reproducibility in drug repositioning
The Connectivity Map (CMap) is a popular resource designed for data-driven drug repositioning using a large transcriptomic compendium. However, evaluations of its performance are limited. We used two iterations of CMap (CMap 1 and 2) to assess their comparability and reliability. We queried CMap 2 w...
Autores principales: | Lim, Nathaniel, Pavlidis, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413422/ https://www.ncbi.nlm.nih.gov/pubmed/34475469 http://dx.doi.org/10.1038/s41598-021-97005-z |
Ejemplares similares
-
DMAP: a connectivity map database to enable identification of novel drug repositioning candidates
por: Huang, Hui, et al.
Publicado: (2015) -
Master Regulators Connectivity Map: A Transcription Factors-Centered Approach to Drug Repositioning
por: De Bastiani, Marco A., et al.
Publicado: (2018) -
Knowledge Mapping of Drug Repositioning’s Theme and Development
por: Lang, Xiaona, et al.
Publicado: (2023) -
Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning
por: Liang, Dong, et al.
Publicado: (2022) -
Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple Myeloma
por: Zhu, Fang-xiao, et al.
Publicado: (2019)